GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy ...

Merck & Co (NYSE: MRK) and Daiichi Sankyo (TYO: 4568) have received Breakthrough Therapy designation from the US regulator ...

Vanda Pharmaceuticals (Nasdaq: VNDA) secured a sweeping victory in its legal battle with the US regulator after the Court of Appeals for the District of Columbia Circuit overturned the agency’s ...

Swedish biotech Anocca has raised about 440 million Swedish kronor ($46 million) in new financing to accelerate development ...

The European Commission (EC) granted marketing authorization for Ogsiveo (nirogacestat), an oral gamma secretase inhibitor, ...

US pharma major Bristol Myers Squibb has appointed Dr Nathan Pennell as senior vice president, worldwide head of medical ...

Privately-held dermatology specialist LEO Pharma today revealed robust growth and significantly improved profitability, ...

Boehringer Ingelheim and Palatin Technologies today announced a global research collaboration and licensing agreement aiming ...

Sweden’s Board for the Assessment of Pharmaceutical Information, NBL, has clarified the regulations for online advertising ...

Brazil’s Fiocruz, through the Drug Technology Institute (Farmanguinhos), and the pharmaceutical company EMS have signed two ...

Australia’s Neurizon Therapeutics saw its shares rise 10% to A$0.16 today. after it revealed that it has been informed by the ...

Japanese drugmaker Eisai today announced that its in-house-discovered and developed orexin receptor antagonist Dayvigo (brand ...